Article
Low HER2 enables dedifferentiation and transformation of normal breast epithelial cells via chromatin opening
2022-09-06
Abstract excerpt
Overexpression of the human epidermal growth factor 2 (HER2) protein in breast cancer patients is a predictor of poor prognosis and resistance to therapies. Despite significant advances in the development of targeted therapies and improvements in the 5-year survival rate of metastatic HER2-positive breast cancer patients, a better understanding of the disease at an early stage is needed to prevent its progression....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 03e294b3-aef9-5924-aff4-e53629a0ff43
- DOI
- 10.1101/2022.09.06.506760
